company background image
DHT logo

Ha Tay Pharmaceutical JSC HNX:DHT Stock Report

Last Price

₫47.80k

Market Cap

₫3.9t

7D

-0.4%

1Y

124.9%

Updated

17 Jun, 2024

Data

Company Financials

DHT Stock Overview

Manufactures, trades in, imports, and exports medicines, chemical raw materials for medicine, medicinal materials, and medical equipment.

DHT fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends2/6

Ha Tay Pharmaceutical JSC Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Ha Tay Pharmaceutical JSC
Historical stock prices
Current Share Price₫47,800.00
52 Week High₫48,600.00
52 Week Low₫18,800.00
Beta0.41
1 Month Change38.15%
3 Month Change90.44%
1 Year Change124.94%
3 Year Change178.83%
5 Year Change324.89%
Change since IPO2,184.51%

Recent News & Updates

Recent updates

Shareholder Returns

DHTVN PharmaceuticalsVN Market
7D-0.4%-1.2%-0.6%
1Y124.9%8.0%13.2%

Return vs Industry: DHT exceeded the VN Pharmaceuticals industry which returned 8% over the past year.

Return vs Market: DHT exceeded the VN Market which returned 13.2% over the past year.

Price Volatility

Is DHT's price volatile compared to industry and market?
DHT volatility
DHT Average Weekly Movement5.9%
Pharmaceuticals Industry Average Movement4.0%
Market Average Movement4.8%
10% most volatile stocks in VN Market7.5%
10% least volatile stocks in VN Market2.7%

Stable Share Price: DHT's share price has been volatile over the past 3 months.

Volatility Over Time: DHT's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of VN stocks.

About the Company

FoundedEmployeesCEOWebsite
1965n/an/awww.hataphar.com.vn

Ha Tay Pharmaceutical JSC manufactures, trades in, imports, and exports medicines, chemical raw materials for medicine, medicinal materials, and medical equipment. It offers functional foods and drugs. In addition, the company provides medicinal products manufacturing services; and import-export authorization services, as well as supplies pharmaceutical ingredients for enterprises.

Ha Tay Pharmaceutical JSC Fundamentals Summary

How do Ha Tay Pharmaceutical JSC's earnings and revenue compare to its market cap?
DHT fundamental statistics
Market cap₫3.94t
Earnings (TTM)₫73.31b
Revenue (TTM)₫2.01t

53.7x

P/E Ratio

2.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
DHT income statement (TTM)
Revenue₫2.01t
Cost of Revenue₫1.81t
Gross Profit₫199.34b
Other Expenses₫126.03b
Earnings₫73.31b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)890.28
Gross Margin9.94%
Net Profit Margin3.65%
Debt/Equity Ratio49.0%

How did DHT perform over the long term?

See historical performance and comparison

Dividends

2.1%

Current Dividend Yield

n/a

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.